Jabil (JBL) 10-Q 9 Jan 24 2024 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Nov. 30, 2023	Jan. 02, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Nov. 30, 2023
Document Transition Report	false
Entity File Number	001-14063
Entity Registrant Name	JABIL INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	38-1886260
Entity Address, Address Line One	10800 Roosevelt Boulevard North
Entity Address, City or Town	St. Petersburg
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33716
City Area Code	727
Local Phone Number	577-9749
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	JBL
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		127,545,611
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000898293
Current Fiscal Year End Date	--08-31

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Nov. 30, 2023	Aug. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,550	$ 1,804
Accounts receivable, net of allowance for credit losses	3,693	3,647
Contract assets	1,090	1,035
Inventories, net of reserve for excess and obsolete inventory	5,124	5,206
Prepaid expenses and other current assets	1,235	1,109
Assets held for sale	1,962	1,929
Total current assets	14,654	14,730
Property, plant and equipment, net of accumulated depreciation of $4,612 as of November 30, 2023 and $4,512 as of August 31, 2023	3,134	3,137
Operating lease right-of-use asset	354	367
Goodwill	661	621
Intangible assets, net of accumulated amortization	177	142
Deferred income taxes	155	159
Other assets	279	268
Total assets	19,414	19,424
Current liabilities:
Current installments of notes payable and long-term debt	0	0
Accounts payable	5,630	5,679
Accrued expenses	5,840	5,515
Current operating lease liabilities	96	104
Liabilities held for sale	1,464	1,397
Total current liabilities	13,030	12,695
Notes payable and long-term debt, less current installments	2,876	2,875
Other liabilities	342	319
Non-current operating lease liabilities	269	269
Income tax liabilities	118	131
Deferred income taxes	243	268
Total liabilities	16,878	16,557
Commitments and contingencies
Jabil Inc. stockholders’ equity:
Preferred stock, $0.001 par value, authorized 10,000,000 shares; no shares issued and no shares outstanding	0	0
Common stock, $0.001 par value, authorized 500,000,000 shares; 275,716,586 and 273,949,811 shares issued and 128,647,431 and 131,294,422 shares outstanding as of November 30, 2023 and August 31, 2023, respectively	0	0
Additional paid-in capital	2,827	2,795
Retained earnings	4,595	4,412
Accumulated other comprehensive loss	(6)	(17)
Treasury stock at cost, 147,069,155 and 142,655,389 shares as of November 30, 2023 and August 31, 2023, respectively	(4,881)	(4,324)
Total Jabil Inc. stockholders’ equity	2,535	2,866
Noncontrolling interests	1	1
Total equity	2,536	2,867
Total liabilities and equity	$ 19,414	$ 19,424

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Nov. 30, 2023	Aug. 31, 2023
Statement of Financial Position [Abstract]
Accumulated depreciation	$ 4,612	$ 4,512
Preferred stock, par value (in usd per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	275,716,586	273,949,811
Common stock, shares outstanding (in shares)	128,647,431	131,294,422
Treasury stock at cost, shares (in shares)	147,069,155	142,655,389

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Income Statement [Abstract]
Net revenue	$ 8,387	$ 9,635
Cost of revenue	7,612	8,892
Gross profit	775	743
Operating expenses:
Selling, general and administrative	314	319
Research and development	10	9
Amortization of intangibles	6	8
Restructuring, severance and related charges	127	45
Costs from the divestiture of businesses	15	0
Operating income	303	362
Other expense	21	15
Interest expense, net	47	48
Income before income tax	235	299
Income tax expense	41	76
Net income	194	223
Net income attributable to noncontrolling interests, net of tax	0	0
Net income attributable to Jabil Inc.	$ 194	$ 223
Earnings per share attributable to the stockholders of Jabil Inc.:
Basic (in usd per share)	$ 1.49	$ 1.65
Diluted (in usd per share)	$ 1.47	$ 1.61
Weighted average shares outstanding:
Basic (in shares)	129.6	134.8
Diluted (in shares)	132.1	138

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 194	$ 223
Other comprehensive income (loss):
Change in foreign currency translation	0	4
Change in derivative instruments:
Change in fair value of derivatives	(3)	(25)
Adjustment for net losses realized and included in net income	16	43
Total change in derivative instruments	13	18
Actuarial loss	(3)	(3)
Prior service credit	1	1
Total other comprehensive income	11	20
Comprehensive income	205	243
Comprehensive income attributable to noncontrolling interests	0	0
Comprehensive income attributable to Jabil Inc.	$ 205	$ 243

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common stock:	Additional paid-in capital:	Retained earnings:	Accumulated other comprehensive loss:	Treasury stock:	Noncontrolling interests:
Beginning Balance at Aug. 31, 2022	$ 2,452		$ 2,655	$ 3,638	$ (42)	$ (3,800)	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Recognition of stock-based compensation			41
Declared dividends				(12)
Net income attributable to Jabil Inc.	223			223
Total other comprehensive income	20				20
Purchases of treasury stock under employee stock plans						(33)
Treasury shares purchased						(161)
Ending Balance at Nov. 30, 2022	2,530	$ 0	2,696	3,849	(22)	(3,994)	1
Beginning Balance at Aug. 31, 2023	2,867		2,795	4,412	(17)	(4,324)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Recognition of stock-based compensation			45
Declared dividends				(11)
Net income attributable to Jabil Inc.	194			194
Total other comprehensive income	11				11
Purchases of treasury stock under employee stock plans						(67)
Treasury shares purchased			(13)			(487)
Excise taxes related to treasury shares purchased						(3)
Ending Balance at Nov. 30, 2023	$ 2,536	$ 0	$ 2,827	$ 4,595	$ (6)	$ (4,881)	$ 1

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Cash flows provided by operating activities:
Net income	$ 194	$ 223
Depreciation, amortization, and other, net	206	263
Change in operating assets and liabilities, exclusive of net assets acquired	48	(320)
Net cash provided by operating activities	448	166
Cash flows used in investing activities:
Acquisition of property, plant and equipment	(288)	(314)
Proceeds and advances from sale of property, plant and equipment	13	150
Cash paid for business and intangible asset acquisitions, net of cash	(59)	0
Proceeds from the divestiture of businesses	258	0
Other, net	1	(12)
Net cash used in investing activities	(75)	(176)
Cash flows used in financing activities:
Borrowings under debt agreements	395	1,026
Payments toward debt agreements	(436)	(1,061)
Payments to acquire treasury stock	(500)	(161)
Dividends paid to stockholders	(12)	(12)
Treasury stock minimum tax withholding related to vesting of restricted stock	(67)	(33)
Net cash used in financing activities	(620)	(241)
Effect of exchange rate changes on cash and cash equivalents	(7)	(10)
Net decrease in cash and cash equivalents	(254)	(261)
Cash and cash equivalents at beginning of period	1,804	1,478
Cash and cash equivalents at end of period	$ 1,550	$ 1,217

Basis of Presentation

Basis of Presentation	3 Months Ended
	Nov. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary to present fairly the information set forth therein have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in the Annual Report on Form 10-K of Jabil Inc. (the “Company”) for the fiscal year ended August 31, 2023. Results for the three months ended November 30, 2023 are not necessarily an indication of the results that may be expected for the full fiscal year ending August 31, 2024.

Trade Accounts Receivable Sale

Trade Accounts Receivable Sale Programs	3 Months Ended
	Nov. 30, 2023
Transfers and Servicing [Abstract]
Trade Accounts Receivable Sale Programs	Trade Accounts Receivable Sale Programs The Company regularly sells designated pools of high credit quality trade accounts receivable, at a discount, under uncommitted trade accounts receivable sale programs to unaffiliated financial institutions without recourse. As these accounts receivable are sold without recourse, the Company does not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions. As of November 30, 2023, the Company may elect to sell receivables and the unaffiliated financial institutions may elect to purchase specific accounts receivable at any one time, at a discount, on an ongoing basis up to a: (i) maximum aggregate amount available of $2.3 billion under nine trade accounts receivable sale programs, (ii) maximum amount available of 100 million CHF under one trade accounts receivable sale program, and (iii) maximum amount available of 8.1 billion INR under one trade accounts receivable sale program. The trade accounts receivable sale programs either expire on various dates through 2028 or do not have expiration dates and may be terminated upon election of the Company or the unaffiliated financial institutions. The Company continues servicing the receivables sold and in exchange receives a servicing fee under each of the trade accounts receivable sale programs. Servicing fees related to the trade accounts receivable sale programs recognized during the three months ended November 30, 2023 and 2022 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities. In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions): Three months ended November 30, 2023 November 30, 2022 Trade accounts receivable sold (1) $ 2,036 $ 3,528 Cash proceeds received $ 2,025 $ 3,518 Pre-tax losses on sale of receivables (2) $ 11 $ 10 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) Recorded to other expense within the Condensed Consolidated Statements of Operations. Certain Jabil entities participating in the global asset-backed securitization program continuously sell designated pools of trade accounts receivable to a special purpose entity, which in turn sells certain of the receivables at a discount to conduits administered by an unaffiliated financial institution on a monthly basis. In addition, a foreign entity participating in the global asset-backed securitization program sells certain receivables at a discount to conduits administered by an unaffiliated financial institution on a daily basis. The Company continues servicing the receivables sold and in exchange receives a servicing fee under the global asset-backed securitization program. Servicing fees related to the global asset-backed securitization program recognized during the three months ended November 30, 2023 and 2022 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities. The special purpose entity in the global asset-backed securitization program is a wholly-owned subsidiary of the Company and is included in the Company’s Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of November 30, 2023. The global asset-backed securitization program expires on November 25, 2024 and the maximum amount of net cash proceeds available at any one time is $600 million. As of November 30, 2023, the Company had no available liquidity under its global asset-backed securitization program. In connection with the asset-backed securitization programs, the Company recognized the following (in millions): Three months ended November 30, 2023 November 30, 2022 Trade accounts receivable sold (1) $ 989 $ 1,066 Cash proceeds received (2) $ 979 $ 1,058 Pre-tax losses on sale of receivables (3) $ 10 $ 8 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) The amounts primarily represent proceeds from collections reinvested in revolving-period transfers. (3) Recorded to other expense within the Condensed Consolidated Statements of Operations.

Inventories

Inventories	3 Months Ended
	Nov. 30, 2023
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories consist of the following (in millions): November 30, 2023 August 31, 2023 Raw materials $ 4,733 $ 4,804 Work in process 241 217 Finished goods 205 243 Reserve for excess and obsolete inventory (55) (58) Inventories, net (1) $ 5,124 $ 5,206 (1) Excludes $354 million and $559 million of inventories, net classified as held for sale as of November 30, 2023 and August 31, 2023, respectively. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

Notes Payable and Long-Term Deb

Notes Payable and Long-Term Debt	3 Months Ended
	Nov. 30, 2023
Debt Disclosure [Abstract]
Notes Payable and Long-Term Debt	Notes Payable and Long-Term Debt Notes payable and long-term debt outstanding as of November 30, 2023 and August 31, 2023 are summarized below (in millions): Maturity Date November 30, 2023 August 31, 2023 3.950% Senior Notes Jan 12, 2028 497 497 3.600% Senior Notes Jan 15, 2030 497 496 3.000% Senior Notes Jan 15, 2031 593 593 1.700% Senior Notes Apr 15, 2026 498 498 4.250% Senior Notes May 15, 2027 495 495 5.450% Senior Notes Feb 1, 2029 296 296 Borrowings under credit facilities (1) Jan 22, 2025 and Jan 22, 2027 — — Borrowings under loans Jul 31, 2026 — — Total notes payable and long-term debt 2,876 2,875 Less current installments of notes payable and long-term debt — — Notes payable and long-term debt, less current installments $ 2,876 $ 2,875 (1) As of November 30, 2023, the Company has $3.8 billion in available unused borrowing capacity under its revolving credit facilities. The senior unsecured credit agreement dated as of January 22, 2020 and amended on February 10, 2023 (the “Credit Facility”) acts as the back-up facility for commercial paper outstanding, if any. The Company has a borrowing capacity of up to $3.2 billion under its commercial paper program. Debt Covenants Borrowings under the Company’s debt agreements are subject to various covenants that limit the Company’s ability to: incur additional indebtedness, sell assets, effect mergers and certain transactions, and effect certain transactions with subsidiaries and affiliates. In addition, the revolving credit facilities contain debt leverage and interest coverage covenants. The Company is also subject to certain covenants requiring the Company to offer to repurchase the 3.950%, 3.600%, 3.000%, 1.700%, 4.250% or 5.450% Senior Notes upon a change of control. As of November 30, 2023 and August 31, 2023, the Company was in compliance with its debt covenants. Fair Value

Asset-Backed Securitization Pro

Asset-Backed Securitization Program	3 Months Ended
	Nov. 30, 2023
Transfers and Servicing [Abstract]
Asset-Backed Securitization Program	Trade Accounts Receivable Sale Programs The Company regularly sells designated pools of high credit quality trade accounts receivable, at a discount, under uncommitted trade accounts receivable sale programs to unaffiliated financial institutions without recourse. As these accounts receivable are sold without recourse, the Company does not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions. As of November 30, 2023, the Company may elect to sell receivables and the unaffiliated financial institutions may elect to purchase specific accounts receivable at any one time, at a discount, on an ongoing basis up to a: (i) maximum aggregate amount available of $2.3 billion under nine trade accounts receivable sale programs, (ii) maximum amount available of 100 million CHF under one trade accounts receivable sale program, and (iii) maximum amount available of 8.1 billion INR under one trade accounts receivable sale program. The trade accounts receivable sale programs either expire on various dates through 2028 or do not have expiration dates and may be terminated upon election of the Company or the unaffiliated financial institutions. The Company continues servicing the receivables sold and in exchange receives a servicing fee under each of the trade accounts receivable sale programs. Servicing fees related to the trade accounts receivable sale programs recognized during the three months ended November 30, 2023 and 2022 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities. In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions): Three months ended November 30, 2023 November 30, 2022 Trade accounts receivable sold (1) $ 2,036 $ 3,528 Cash proceeds received $ 2,025 $ 3,518 Pre-tax losses on sale of receivables (2) $ 11 $ 10 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) Recorded to other expense within the Condensed Consolidated Statements of Operations. Certain Jabil entities participating in the global asset-backed securitization program continuously sell designated pools of trade accounts receivable to a special purpose entity, which in turn sells certain of the receivables at a discount to conduits administered by an unaffiliated financial institution on a monthly basis. In addition, a foreign entity participating in the global asset-backed securitization program sells certain receivables at a discount to conduits administered by an unaffiliated financial institution on a daily basis. The Company continues servicing the receivables sold and in exchange receives a servicing fee under the global asset-backed securitization program. Servicing fees related to the global asset-backed securitization program recognized during the three months ended November 30, 2023 and 2022 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities. The special purpose entity in the global asset-backed securitization program is a wholly-owned subsidiary of the Company and is included in the Company’s Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of November 30, 2023. The global asset-backed securitization program expires on November 25, 2024 and the maximum amount of net cash proceeds available at any one time is $600 million. As of November 30, 2023, the Company had no available liquidity under its global asset-backed securitization program. In connection with the asset-backed securitization programs, the Company recognized the following (in millions): Three months ended November 30, 2023 November 30, 2022 Trade accounts receivable sold (1) $ 989 $ 1,066 Cash proceeds received (2) $ 979 $ 1,058 Pre-tax losses on sale of receivables (3) $ 10 $ 8 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) The amounts primarily represent proceeds from collections reinvested in revolving-period transfers. (3) Recorded to other expense within the Condensed Consolidated Statements of Operations.

Accrued Expenses

Accrued Expenses	3 Months Ended
	Nov. 30, 2023
Accrued Liabilities, Current [Abstract]
Accrued Expenses	Accrued Expenses Accrued expenses consist of the following (in millions): November 30, 2023 August 31, 2023 Inventory deposits $ 1,656 $ 1,839 Contract liabilities (1) 906 886 Accrued compensation and employee benefits 683 743 Other accrued expenses 2,595 2,047 Accrued expenses (2) $ 5,840 $ 5,515 (1) Revenue recognized during the three months ended November 30, 2023 and 2022 that was included in the contract liability balance as of August 31, 2023 and 2022 was $161 million and $139 million , respectively. (2) Excludes $304 million and $364 million of accrued expenses classified as held for sale as of November 30, 2023 and August 31, 2023, respectively. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

Postretirement and Other Employ

Postretirement and Other Employee Benefits	3 Months Ended
	Nov. 30, 2023
Retirement Benefits [Abstract]
Postretirement and Other Employee Benefits	Postretirement and Other Employee Benefits Net Periodic Benefit Cost The following table provides information about the net periodic benefit cost for all plans for the three months ended November 30, 2023 and 2022 (in millions): Three months ended November 30, 2023 November 30, 2022 Service cost (1) $ 5 $ 4 Interest cost (2) 3 3 Expected long-term return on plan assets (2) (4) (5) Recognized actuarial gain (2) (2) (2) Amortization of actuarial gain (2)(3) (1) (1) Amortization of prior service cost (2) 1 1 Net periodic benefit cost $ 2 $ — (1) Service cost is recognized in cost of revenue in the Condensed Consolidated Statements of Operations. (2) Components are recognized in other expense in the Condensed Consolidated Statements of Operations. (3) Actuarial gains and losses are amortized using a corridor approach. The gain/loss corridor is equal to 10 percent of the greater of the projected benefit obligation and the fair value of plan assets. Gains and losses in excess of the corridor are generally amortized over the average future working lifetime of the plan participants.

Derivative Financial Instrument

Derivative Financial Instruments and Hedging Activities	3 Months Ended
	Nov. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments and Hedging Activities	Derivative Financial Instruments and Hedging Activities The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company’s financial performance and are referred to as market risks. The Company, where deemed appropriate, uses derivatives as risk management tools to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency risk and interest rate risk. Foreign Currency Risk Management Forward contracts are put in place to manage the foreign currency risk associated with the anticipated foreign currency denominated revenues and expenses. A hedging relationship existed with an aggregate notional amount outstanding of $153 million and $491 million as of November 30, 2023 and August 31, 2023, respectively. The related forward foreign exchange contracts have been designated as hedging instruments and are accounted for as cash flow hedges. The forward foreign exchange contract transactions will effectively lock in the value of anticipated foreign currency denominated revenues and expenses against foreign currency fluctuations. The anticipated foreign currency denominated revenues and expenses being hedged are expected to occur between December 1, 2023 and August 31, 2024. In addition to derivatives that are designated as hedging instruments and qualify for hedge accounting, the Company also enters into forward contracts to economically hedge transactional exposure associated with commitments arising from trade accounts receivable, trade accounts payable, fixed purchase obligations and intercompany transactions denominated in a currency other than the functional currency of the respective operating entity. The aggregate notional amount of these outstanding contracts as of November 30, 2023 and August 31, 2023, was $4.3 billion and $4.0 billion, respectively. The gains and losses on cash flow hedges recognized in earnings due to amounts excluded from effectiveness testing were not material for all periods presented and are included as components of net revenue, cost of revenue and selling, general and administrative expense, which are the same line items in which the hedged items are recorded. In addition, the Company has entered into forward foreign currency exchange contracts to hedge a portion of its net investment in foreign currency denominated operations, which are designated as net investment hedges. The maturity dates and aggregate notional amount outstanding of net investment hedges are as follows (in millions): Maturity date November 30, 2023 August 31, 2023 September 2023 $ — $ 34 October 2023 — 96 January 2024 97 96 April 2024 104 68 July 2024 174 102 Total $ 375 $ 396 The gains and losses on net investment hedges are included in change in foreign currency translation in OCI to offset the change in the carrying value of the net investment being hedged until the complete or substantially complete liquidation of the hedged foreign operation. The amounts excluded from effectiveness testing were not material for all periods presented and are recognized in interest expense, net. Refer to Note 16 – “Fair Value Measurements” for the fair values and classification of the Company’s derivative instruments. The following table presents the net gains (losses) from forward contracts recorded in the Condensed Consolidated Statements of Operations for the periods indicated (in millions): Derivatives Not Designated as Hedging Instruments Under ASC 815 Location of Gain (Loss) on Derivatives Recognized in Net Income Amount of Gain (Loss) Recognized in Net Income on Derivatives Three months ended November 30, 2023 November 30, 2022 Forward foreign exchange contracts (1) Cost of revenue $ 18 $ (46) (1) For the three months ended November 30, 2023, the Company recognized $38 million of foreign currency losses in cost of revenue, which are offset by the gains from the forward foreign exchange contracts. For the three months ended November 30, 2022, the Company recognized $49 million of foreign currency gains in cost of revenue, which are offset by the losses from the forward foreign exchange contracts. Interest Rate Risk Management

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	3 Months Ended
	Nov. 30, 2023
Equity [Abstract]
Accumulated Other Comprehensive Income	Accumulated Other Comprehensive Income The following table sets forth the changes in AOCI, net of tax, by component for the three months ended November 30, 2023 (in millions): Foreign Currency Net Investment Hedges Derivative Actuarial Gain (Loss) Prior Service (Cost) Credit Total Balance as of August 31, 2023 $ (59) $ (4) $ 14 $ 46 $ (14) $ (17) Other comprehensive income (loss) before reclassifications 4 (4) (3) — — (3) Amounts reclassified from AOCI — — 16 (3) 1 14 Other comprehensive income (loss) (1) 4 (4) 13 (3) 1 11 Balance as of November 30, 2023 $ (55) $ (8) $ 27 $ 43 $ (13) $ (6) (1) Amounts are net of tax, which are immaterial. The following table sets forth the amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, net of tax, for the periods indicated (in millions): Three months ended Comprehensive Income Components Financial Statement Line Item November 30, 2023 November 30, 2022 Realized losses (gains) on derivative instruments: (1) Foreign exchange contracts Cost of revenue $ 17 $ 43 Interest rate contracts Interest expense, net (1) — Actuarial gains (2) (3) (3) Prior service costs (2) 1 1 Total amounts reclassified from AOCI (3) $ 14 $ 41 (1) The Company expects to reclassify $5 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue. (2) Amounts are included in the computation of net periodic benefit cost. Refer to Note 7 – “Postretirement and Other Employee Benefits” for additional information. (3) Amounts are net of tax, which are immaterial for the three months ended November 30, 2023 and 2022.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Nov. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stockholders' Equity	Stockholders’ Equity The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions): Three months ended November 30, 2023 November 30, 2022 Restricted stock units $ 42 $ 38 Employee stock purchase plan 4 4 Total $ 46 $ 42 As of November 30, 2023 , the shares available to be issued under t he 2021 Equity Incentive Plan were 7,738,300. Restricted Stock Units Certain key employees have been granted time-based, performance-based and market-based restricted stock unit awards (“restricted stock units”). The time-based restricted stock units generally vest on a graded vesting schedule over three years. The performance-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 150%, depending on the specified performance condition and the level of achievement obtained. The performance-based restricted stock units have a vesting condition that is based upon the Company’s cumulative adjusted core earnings per share during the performance period. The market-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 200%, depending on the specified performance condition and the level of achievement obtained. The market-based restricted stock units have a vesting condition that is tied to the Company’s total shareholder return based on the Company’s stock performance in relation to the companies in the Standard and Poor’s (S&P) Super Composite Technology Hardware and Equipment Index excluding the Company. During the three months ended November 30, 2023 and 2022, the Company awarded approximately 0.4 million and 0.9 million time-based restricted stock units, respectively, 0.1 million and 0.2 million performance-based restricted stock units, respectively, and 0.1 million and 0.2 million market-based restricted stock units, respectively. The following represents the stock-based compensation information as of the period indicated (in millions): November 30, 2023 Unrecognized stock-based compensation expense – restricted stock units $ 82 Remaining weighted-average period for restricted stock units expense 1.5 years Common Stock Outstanding The following represents the common stock outstanding for the periods indicated: Three months ended November 30, 2023 November 30, 2022 Common stock outstanding: Beginning balances 131,294,422 135,493,980 Vesting of restricted stock 1,766,775 1,861,678 Purchases of treasury stock under employee stock plans (526,028) (523,407) Treasury shares purchased (1)(2) (3,887,738) (2,600,951) Ending balances 128,647,431 134,231,300 (1) In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2022 Share Repurchase Program”). As of February 28, 2023, 16.5 million shares had been repurchased for $1.0 billion and no authorization remained under the 2022 Share Repurchase Program. (2) In September 2022, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2023 Share Repurchase Program”). As of August 31, 2023, 2.7 million shares had been repurchased for $224 million, excluding excise tax. In September 2023, the Board of Directors amended and increased the 2023 Share Repurchase Program to allow for the repurchase of up to $2.5 billion of the Company’s common stock. As part of the 2023 Share Repurchase Program, the Company entered into an accelerated share repurchase (“ASR”) agreement with a bank in September 2023 to repurchase $500 million of the Company’s common stock. During the first quarter of 2024, the ASR transaction was completed, and 3.9 million shares were delivered under the ASR agreement at an average price of $128.61. The final number of shares delivered upon settlement of the ASR agreement was determined based on a discount to the volume weighted average price of the Company’s common stock during the term of the agreement. As of November 30, 2023, 3.9 million shares had been repurchased for $500 million, excluding excise tax, and $2.0 billion remains available under the 2023 Share Repurchase Program approved in September 2023.

Concentration of Risk and Segme

Concentration of Risk and Segment Data	3 Months Ended
	Nov. 30, 2023
Segment Reporting [Abstract]
Concentration of Risk and Segment Data	Concentration of Risk and Segment Data Concentration of Risk Sales of the Company’s products are concentrated among specific customers. During the three months ended November 30, 2023, the Company’s five largest customers accounted for approximately 44% of its net revenue and 76 customers accounted for approximately 90% of its net revenue. Sales to these customers were reported in the Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”) operating segments. The Company procures components from a broad group of suppliers. Some of the products manufactured by the Company require one or more components that are available from only a single source. Segment Data Net revenue for the operating segments is attributed to the segment in which the service is performed. An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net revenue less cost of revenue, segment selling, general and administrative expenses, segment research and development expenses and an allocation of corporate manufacturing expenses and selling, general and administrative expenses. Certain items are excluded from the calculation of segment income. Transactions between operating segments are generally recorded at amounts that approximate those at which we would transact with third parties. The following table sets forth operating segment information (in millions): Three months ended November 30, 2023 November 30, 2022 Segment income and reconciliation of income before income tax EMS $ 165 $ 198 DMS 334 263 Total segment income $ 499 $ 461 Reconciling items: Amortization of intangibles (6) (8) Stock-based compensation expense and related charges (46) (42) Restructuring, severance and related charges (127) (45) Costs from the divestiture of businesses (15) — Other expense (net of periodic benefit cost) (23) (19) Interest expense, net (47) (48) Income before income tax $ 235 $ 299 The following table presents the Company’s revenues disaggregated by segment (in millions): Three months ended November 30, 2023 November 30, 2022 EMS DMS Total EMS DMS Total Timing of transfer Point in time $ 1,095 $ 2,014 $ 3,109 $ 1,538 $ 2,280 $ 3,818 Over time 2,497 2,781 5,278 3,008 2,809 5,817 Total $ 3,592 $ 4,795 $ 8,387 $ 4,546 $ 5,089 $ 9,635 The Company operates in more than 30 countries worldwide. Sales to unaffiliated customers are based on the Company location that maintains the customer relationship and transacts the external sale. The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue: Three months ended November 30, 2023 November 30, 2022 Foreign source revenue 86.4 % 85.7 %

Restructuring, Severance and Re

Restructuring, Severance and Related Charges	3 Months Ended
	Nov. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring, Severance and Related Charges	Restructuring, Severance and Related Charges Following is a summary of the Company’s restructuring, severance and related charges (in millions): Three months ended November 30, 2023 November 30, 2022 Employee severance and benefit costs $ 95 $ 40 Asset write-off costs 22 1 Other costs 10 4 Total restructuring, severance and related charges (1) $ 127 $ 45 (1) Charges for the three months ended November 30, 2023, related to the 2024 Restructuring Plan and included $29 million recorded in the EMS segment, $79 million recorded in the DMS segment and $19 million of non-allocated charges. Charges for the three months ended November 30, 2022, related to headcount reduction to further optimize the Company’s business activities and included $4 million recorded in the EMS segment, $33 million recorded in the DMS segment and $8 million of non-allocated charges. Except for asset write-off costs, all restructuring, severance and related charges are cash costs. 2024 Restructuring Plan On September 26, 2023, the Company’s Board of Directors approved a restructuring plan to (i) realign the Company’s cost base for stranded costs associated with the Company’s sale and realignment of its mobility business and (ii) optimize the Company’s global footprint. This action includes headcount reductions across our Selling, General and Administrative (“SG&A”) cost base and capacity realignment (the “2024 Restructuring Plan”). The 2024 Restructuring Plan reflects the Company’s intention only and restructuring decisions, and the timing of such decisions, at certain locations, are still subject to consultation with the Company’s employees and their representatives. The Company currently expects to recognize approximately $300 million in pre-tax restructuring and other related costs over the course of the Company’s 2024 fiscal year. This information will be subject to the finalization of timetables for the transition of functions, consultation with employees and their representatives as well as the statutory severance requirements of the jurisdictions impacted, and the amount and timing of the actual charges may vary due to a variety of factors. The Company’s estimates for the charges discussed above exclude any potential income tax effects. The table below summarizes the Company’s liability activity, primarily associated with the 2024 Restructuring Plan (in millions): Employee Lease Costs Asset Write-off Costs Other Related Costs Total Balance as of August 31, 2023 $ — $ — $ — $ — $ — Restructuring related charges 95 — 22 10 127 Asset write-off charge and other non-cash activity — — (22) (5) (27) Cash payments (14) — — — (14) Balance as of November 30, 2023 $ 81 $ — $ — $ 5 $ 86

Income Taxes

Income Taxes	3 Months Ended
	Nov. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Effective Income Tax Rate The U.S. federal statutory income tax rate and the Company's effective income tax rate are as follows: Three months ended November 30, 2023 November 30, 2022 U.S. federal statutory income tax rate 21.0 % 21.0 % Effective income tax rate 17.6 % 25.6 % The effective income tax rate differed for the three months ended November 30, 2023, compared to the three months ended November 30, 2022, primarily due to: (i) a change in the jurisdictional mix of earnings, driven in part by restructuring charges, (ii) a $19 million income tax benefit for the reversal of a non-U.S. unrecognized tax benefit due to audit closure for the three months ended November 30, 2023, and (iii) an $11 million income tax benefit for the reversal of a portion of the U.S. valuation allowance related to an acquisition for the three months ended November 30, 2023.

Earnings Per Share and Dividend

Earnings Per Share and Dividends	3 Months Ended
	Nov. 30, 2023
Earnings Per Share [Abstract]
Earnings Per Share and Dividends	Earnings Per Share and Dividends Earnings Per Share The Company calculates its basic earnings per share by dividing net income attributable to the Company by the weighted average number of common shares outstanding during the period. The Company’s diluted earnings per share is calculated in a similar manner, but includes the effect of dilutive securities. The difference between the weighted average number of basic shares outstanding and the weighted average number of diluted shares outstanding is primarily due to dilutive unvested restricted stock units. Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be antidilutive. Performance-based restricted stock units are considered dilutive when the related performance criteria have been met assuming the end of the reporting period represents the end of the performance period. All potential shares of common stock are antidilutive in periods of net loss. Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands): Three months ended November 30, 2023 November 30, 2022 Restricted stock units 654.4 365.9 Dividends The following table sets forth cash dividends declared by the Company to common stockholders during the three months ended November 30, 2023 and 2022 (in millions, except for per share data): Dividend Dividend Total of Cash Date of Record for Dividend Cash Fiscal Year 2024: October 19, 2023 $ 0.08 $ 11 November 15, 2023 December 4, 2023 Fiscal Year 2023: October 20, 2022 $ 0.08 $ 12 November 15, 2022 December 2, 2022

Business Acquisitions and Dives

Business Acquisitions and Divestitures	3 Months Ended
	Nov. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Business Acquisitions and Divestitures	Business Acquisitions and Divestitures Acquisitions On November 1, 2023, the Company completed the acquisition of ProcureAbility Inc. (“ProcureAbility”) for approximately $60 million in cash. ProcureAbility is a procurement services provider specializing in technology-enabled advisory, managed services, digital, staffing, and recruiting solutions. The acquisition of ProcureAbility assets was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $86 million, including $40 million in intangible assets and $38 million in goodwill, and liabilities assumed of $25 million were recorded at their estimated fair values as of the acquisition date. The allocation of the purchase price is considered preliminary pending final valuation for the Company. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the DMS segment. The majority of the goodwill is currently not expected to be deductible for income tax purposes. The results of operations were included in the Company’s condensed consolidated financial results beginning on November 1, 2023. Pro forma information has not been provided as the acquisition of ProcureAbility is not deemed to be significant. Divestitures The Company announced on September 26, 2023 that, through its indirect subsidiary, Jabil Circuit (Singapore) Pte. Ltd., a Singapore private limited company (“Singapore Seller”), it agreed to sell to an affiliate of BYD Electronic (International) Co. Ltd., a Hong Kong limited liability company (“Purchaser” or “BYDE”), its product manufacturing business in Chengdu, including its supporting component manufacturing in Wuxi (the “Business”) for cash consideration of approximately $2.2 billion, subject to certain customary purchase price adjustments. On December 29, 2023 (the “Closing Date”), the Company completed the sale. As of November 30, 2023, and August 31, 2023, the assets and liabilities of the Business were classified as held for sale and the carrying value is less than the estimated fair value less cost to sell and, thus, no adjustment to the carrying value of the disposal group is necessary. For the three months ended November 30, 2023, depreciation and amortization expense for long-lived assets are not recorded while these assets are classified as held for sale. The divestiture did not meet the criteria to be reported as discontinued operations and the Company continued to report the operating results for the Business in the Company’s Condensed Consolidated Statement of Operations in the DMS segment until the Closing Date. Following is a summary of the carrying amounts of the major classes of assets and liabilities that were classified as held for sale (in millions): November 30, 2023 August 31, 2023 Assets held for sale: Accounts receivable, net of allowance for credit losses $ 315 $ 96 Inventories, net of reserve for excess and obsolete inventory 354 559 Prepaid expenses and other current assets 153 220 Property, plant and equipment, net of accumulated depreciation 812 724 Operating lease right-of-use asset 119 112 Goodwill 117 117 Deferred income taxes 86 96 Liabilities held for sale: Accounts payable $ 992 $ 876 Accrued expenses 304 364 Non-current operating lease liabilities 86 83

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Nov. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair Value Measurements on a Recurring Basis The following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated (in millions): Fair Value Hierarchy November 30, 2023 August 31, 2023 Assets: Prepaid expenses and other current assets: Short-term investments Level 1 $ 25 $ 25 Forward foreign exchange contracts: Derivatives designated as hedging instruments (Note 8) Level 2 (1) 10 4 Derivatives not designated as hedging instruments (Note 8) Level 2 (1) 18 20 Net investment hedges: Derivatives designated as hedging instruments (Note 8) Level 2 (1) 5 9 Liabilities: Accrued expenses: Forward foreign exchange contracts: Derivatives designated as hedging instruments (Note 8) Level 2 (1) $ 5 $ 17 Derivatives not designated as hedging instruments (Note 8) Level 2 (1) 17 64 Net investment hedges: Derivatives designated as hedging instruments (Note 8) Level 2 (1) 3 1 (1) The Company’s forward foreign exchange contracts, including cash flow hedges and net investment hedges are measured on a recurring basis at fair value, based on foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. Fair Value of Financial Instruments The carrying amounts of cash and cash equivalents, trade accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value because of the short-term nature of these financial instruments. The carrying amounts of borrowings under credit facilities and under loans approximates fair value as interest rates on these instruments approximates current market rates. Notes payable and long-term debt is carried at amortized cost; however, the Company estimates the fair values of notes payable and long-term debt for disclosure purposes. The following table presents the carrying amounts and fair values of the Company's notes payable and long-term debt, by hierarchy level as of the periods indicated (in millions): November 30, 2023 August 31, 2023 Fair Value Hierarchy Carrying Amount Fair Value Carrying Amount Fair Value Notes payable and long-term debt: (Note 4) 3.950% Senior Notes Level 2 (1) $ 497 $ 469 $ 497 $ 468 3.600% Senior Notes Level 2 (1) $ 497 $ 444 $ 496 $ 448 3.000% Senior Notes Level 2 (1) $ 593 $ 505 $ 593 $ 502 1.700% Senior Notes Level 2 (1) $ 498 $ 459 $ 498 $ 452 4.250% Senior Notes Level 2 (1) $ 495 $ 481 $ 495 $ 478 5.450% Senior Notes Level 2 (1) $ 296 $ 298 $ 296 $ 297 (1)

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Nov. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Proceedings The Company is party to certain lawsuits in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial position, results of operations or cash flows.

New Accounting Guidance

New Accounting Guidance	3 Months Ended
	Nov. 30, 2023
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Guidance	New Accounting Guidance New accounting guidance adopted during the period did not have a material impact to the Company. Recently issued accounting guidance is not applicable or did not have, or is not expected to have, a material impact to the Company.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 194	$ 223

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Nov. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

New Accounting Guidance (Polici

New Accounting Guidance (Policies)	3 Months Ended
	Nov. 30, 2023
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Guidance	New accounting guidance adopted during the period did not have a material impact to the Company. Recently issued accounting guidance is not applicable or did not have, or is not expected to have, a material impact to the Company.

Trade Accounts Receivable Sal_2

Trade Accounts Receivable Sale Programs (Tables)	3 Months Ended
	Nov. 30, 2023
Transfers and Servicing [Abstract]
Schedule of Trade Accounts Receivable Sale Programs Amounts Recognized	In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions): Three months ended November 30, 2023 November 30, 2022 Trade accounts receivable sold (1) $ 2,036 $ 3,528 Cash proceeds received $ 2,025 $ 3,518 Pre-tax losses on sale of receivables (2) $ 11 $ 10 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) Recorded to other expense within the Condensed Consolidated Statements of Operations.

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Nov. 30, 2023
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consist of the following (in millions): November 30, 2023 August 31, 2023 Raw materials $ 4,733 $ 4,804 Work in process 241 217 Finished goods 205 243 Reserve for excess and obsolete inventory (55) (58) Inventories, net (1) $ 5,124 $ 5,206 (1) Excludes $354 million and $559 million of inventories, net classified as held for sale as of November 30, 2023 and August 31, 2023, respectively. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

Notes Payable and Long-Term D_2

Notes Payable and Long-Term Debt (Tables)	3 Months Ended
	Nov. 30, 2023
Debt Disclosure [Abstract]
Schedule of Notes Payable and Long-term Debt	Notes payable and long-term debt outstanding as of November 30, 2023 and August 31, 2023 are summarized below (in millions): Maturity Date November 30, 2023 August 31, 2023 3.950% Senior Notes Jan 12, 2028 497 497 3.600% Senior Notes Jan 15, 2030 497 496 3.000% Senior Notes Jan 15, 2031 593 593 1.700% Senior Notes Apr 15, 2026 498 498 4.250% Senior Notes May 15, 2027 495 495 5.450% Senior Notes Feb 1, 2029 296 296 Borrowings under credit facilities (1) Jan 22, 2025 and Jan 22, 2027 — — Borrowings under loans Jul 31, 2026 — — Total notes payable and long-term debt 2,876 2,875 Less current installments of notes payable and long-term debt — — Notes payable and long-term debt, less current installments $ 2,876 $ 2,875 (1) As of November 30, 2023, the Company has $3.8 billion in available unused borrowing capacity under its revolving credit facilities. The senior unsecured credit agreement dated as of January 22, 2020 and amended on February 10, 2023 (the “Credit Facility”) acts as the back-up facility for commercial paper outstanding, if any. The Company has a borrowing capacity of up to $3.2 billion under its commercial paper program.

Asset-Backed Securitization P_2

Asset-Backed Securitization Program (Tables)	3 Months Ended
	Nov. 30, 2023
Transfers and Servicing [Abstract]
Schedule of Asset-backed Securitization Programs Amounts Recognized	In connection with the asset-backed securitization programs, the Company recognized the following (in millions): Three months ended November 30, 2023 November 30, 2022 Trade accounts receivable sold (1) $ 989 $ 1,066 Cash proceeds received (2) $ 979 $ 1,058 Pre-tax losses on sale of receivables (3) $ 10 $ 8 (1) Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. (2) The amounts primarily represent proceeds from collections reinvested in revolving-period transfers. (3) Recorded to other expense within the Condensed Consolidated Statements of Operations.

Accrued Expenses (Tables)

Accrued Expenses (Tables)	3 Months Ended
	Nov. 30, 2023
Accrued Liabilities, Current [Abstract]
Schedule of Accrued Expenses	Accrued expenses consist of the following (in millions): November 30, 2023 August 31, 2023 Inventory deposits $ 1,656 $ 1,839 Contract liabilities (1) 906 886 Accrued compensation and employee benefits 683 743 Other accrued expenses 2,595 2,047 Accrued expenses (2) $ 5,840 $ 5,515 (1) Revenue recognized during the three months ended November 30, 2023 and 2022 that was included in the contract liability balance as of August 31, 2023 and 2022 was $161 million and $139 million , respectively. (2) Excludes $304 million and $364 million of accrued expenses classified as held for sale as of November 30, 2023 and August 31, 2023, respectively. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

Postretirement and Other Empl_2

Postretirement and Other Employee Benefits (Tables)	3 Months Ended
	Nov. 30, 2023
Retirement Benefits [Abstract]
Schedule of Information about Net Periodic Benefit Cost	The following table provides information about the net periodic benefit cost for all plans for the three months ended November 30, 2023 and 2022 (in millions): Three months ended November 30, 2023 November 30, 2022 Service cost (1) $ 5 $ 4 Interest cost (2) 3 3 Expected long-term return on plan assets (2) (4) (5) Recognized actuarial gain (2) (2) (2) Amortization of actuarial gain (2)(3) (1) (1) Amortization of prior service cost (2) 1 1 Net periodic benefit cost $ 2 $ — (1) Service cost is recognized in cost of revenue in the Condensed Consolidated Statements of Operations. (2) Components are recognized in other expense in the Condensed Consolidated Statements of Operations. (3) Actuarial gains and losses are amortized using a corridor approach. The gain/loss corridor is equal to 10 percent of the greater of the projected benefit obligation and the fair value of plan assets. Gains and losses in excess of the corridor are generally amortized over the average future working lifetime of the plan participants.

Derivative Financial Instrume_2

Derivative Financial Instruments and Hedging Activities (Tables)	3 Months Ended
	Nov. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Maturity Date and Aggregate Notional Amount Outstanding of Net Investment Hedges	The maturity dates and aggregate notional amount outstanding of net investment hedges are as follows (in millions): Maturity date November 30, 2023 August 31, 2023 September 2023 $ — $ 34 October 2023 — 96 January 2024 97 96 April 2024 104 68 July 2024 174 102 Total $ 375 $ 396
Schedule of Net Gains (Losses) from Forward Contracts Recorded in Consolidated Statements of Operations	The following table presents the net gains (losses) from forward contracts recorded in the Condensed Consolidated Statements of Operations for the periods indicated (in millions): Derivatives Not Designated as Hedging Instruments Under ASC 815 Location of Gain (Loss) on Derivatives Recognized in Net Income Amount of Gain (Loss) Recognized in Net Income on Derivatives Three months ended November 30, 2023 November 30, 2022 Forward foreign exchange contracts (1) Cost of revenue $ 18 $ (46) (1)

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	3 Months Ended
	Nov. 30, 2023
Equity [Abstract]
Schedule of Changes in AOCI	The following table sets forth the changes in AOCI, net of tax, by component for the three months ended November 30, 2023 (in millions): Foreign Currency Net Investment Hedges Derivative Actuarial Gain (Loss) Prior Service (Cost) Credit Total Balance as of August 31, 2023 $ (59) $ (4) $ 14 $ 46 $ (14) $ (17) Other comprehensive income (loss) before reclassifications 4 (4) (3) — — (3) Amounts reclassified from AOCI — — 16 (3) 1 14 Other comprehensive income (loss) (1) 4 (4) 13 (3) 1 11 Balance as of November 30, 2023 $ (55) $ (8) $ 27 $ 43 $ (13) $ (6) (1) Amounts are net of tax, which are immaterial.
Schedule of Reclassification from AOCI	The following table sets forth the amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, net of tax, for the periods indicated (in millions): Three months ended Comprehensive Income Components Financial Statement Line Item November 30, 2023 November 30, 2022 Realized losses (gains) on derivative instruments: (1) Foreign exchange contracts Cost of revenue $ 17 $ 43 Interest rate contracts Interest expense, net (1) — Actuarial gains (2) (3) (3) Prior service costs (2) 1 1 Total amounts reclassified from AOCI (3) $ 14 $ 41 (1) The Company expects to reclassify $5 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue. (2) Amounts are included in the computation of net periodic benefit cost. Refer to Note 7 – “Postretirement and Other Employee Benefits” for additional information. (3) Amounts are net of tax, which are immaterial for the three months ended November 30, 2023 and 2022.

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Nov. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Recognized Stock-based Compensation Expense	The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions): Three months ended November 30, 2023 November 30, 2022 Restricted stock units $ 42 $ 38 Employee stock purchase plan 4 4 Total $ 46 $ 42
Schedule of Share-based Compensation Information	The following represents the stock-based compensation information as of the period indicated (in millions): November 30, 2023 Unrecognized stock-based compensation expense – restricted stock units $ 82 Remaining weighted-average period for restricted stock units expense 1.5 years
Schedule of Common Stock Outstanding	The following represents the common stock outstanding for the periods indicated: Three months ended November 30, 2023 November 30, 2022 Common stock outstanding: Beginning balances 131,294,422 135,493,980 Vesting of restricted stock 1,766,775 1,861,678 Purchases of treasury stock under employee stock plans (526,028) (523,407) Treasury shares purchased (1)(2) (3,887,738) (2,600,951) Ending balances 128,647,431 134,231,300 (1) In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2022 Share Repurchase Program”). As of February 28, 2023, 16.5 million shares had been repurchased for $1.0 billion and no authorization remained under the 2022 Share Repurchase Program. (2) In September 2022, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2023 Share Repurchase Program”). As of August 31, 2023, 2.7 million shares had been repurchased for $224 million, excluding excise tax. In September 2023, the Board of Directors amended and increased the 2023 Share Repurchase Program to allow for the repurchase of up to $2.5 billion of the Company’s common stock. As part of the 2023 Share Repurchase Program, the Company entered into an accelerated share repurchase (“ASR”) agreement with a bank in September 2023 to repurchase $500 million of the Company’s common stock. During the first quarter of 2024, the ASR transaction was completed, and 3.9 million shares were delivered under the ASR agreement at an average price of $128.61. The final number of shares delivered upon settlement of the ASR agreement was determined based on a discount to the volume weighted average price of the Company’s common stock during the term of the agreement. As of November 30, 2023, 3.9 million shares had been repurchased for $500 million, excluding excise tax, and $2.0 billion remains available under the 2023 Share Repurchase Program approved in September 2023.

Concentration of Risk and Seg_2

Concentration of Risk and Segment Data (Tables)	3 Months Ended
	Nov. 30, 2023
Segment Reporting [Abstract]
Schedule of Segment Income	The following table sets forth operating segment information (in millions): Three months ended November 30, 2023 November 30, 2022 Segment income and reconciliation of income before income tax EMS $ 165 $ 198 DMS 334 263 Total segment income $ 499 $ 461 Reconciling items: Amortization of intangibles (6) (8) Stock-based compensation expense and related charges (46) (42) Restructuring, severance and related charges (127) (45) Costs from the divestiture of businesses (15) — Other expense (net of periodic benefit cost) (23) (19) Interest expense, net (47) (48) Income before income tax $ 235 $ 299
Schedule of Revenues Disaggregated by Segment	The following table presents the Company’s revenues disaggregated by segment (in millions): Three months ended November 30, 2023 November 30, 2022 EMS DMS Total EMS DMS Total Timing of transfer Point in time $ 1,095 $ 2,014 $ 3,109 $ 1,538 $ 2,280 $ 3,818 Over time 2,497 2,781 5,278 3,008 2,809 5,817 Total $ 3,592 $ 4,795 $ 8,387 $ 4,546 $ 5,089 $ 9,635
Schedule of Foreign Source Revenue	The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue: Three months ended November 30, 2023 November 30, 2022 Foreign source revenue 86.4 % 85.7 %

Restructuring, Severance and _2

Restructuring, Severance and Related Charges (Tables)	3 Months Ended
	Nov. 30, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring, Severance and Related Charges and Liability Activity	Following is a summary of the Company’s restructuring, severance and related charges (in millions): Three months ended November 30, 2023 November 30, 2022 Employee severance and benefit costs $ 95 $ 40 Asset write-off costs 22 1 Other costs 10 4 Total restructuring, severance and related charges (1) $ 127 $ 45 (1) Charges for the three months ended November 30, 2023, related to the 2024 Restructuring Plan and included $29 million recorded in the EMS segment, $79 million recorded in the DMS segment and $19 million of non-allocated charges. Charges for the three months ended November 30, 2022, related to headcount reduction to further optimize the Company’s business activities and included $4 million recorded in the EMS segment, $33 million recorded in the DMS segment and $8 million of non-allocated charges. Except for asset write-off costs, all restructuring, severance and related charges are cash costs. The table below summarizes the Company’s liability activity, primarily associated with the 2024 Restructuring Plan (in millions): Employee Lease Costs Asset Write-off Costs Other Related Costs Total Balance as of August 31, 2023 $ — $ — $ — $ — $ — Restructuring related charges 95 — 22 10 127 Asset write-off charge and other non-cash activity — — (22) (5) (27) Cash payments (14) — — — (14) Balance as of November 30, 2023 $ 81 $ — $ — $ 5 $ 86

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Nov. 30, 2023
Income Tax Disclosure [Abstract]
Schedule of U.S. Federal Statutory Income Tax Rate Compared to Actual Income Tax Expense	The U.S. federal statutory income tax rate and the Company's effective income tax rate are as follows: Three months ended November 30, 2023 November 30, 2022 U.S. federal statutory income tax rate 21.0 % 21.0 % Effective income tax rate 17.6 % 25.6 %

Earnings Per Share and Divide_2

Earnings Per Share and Dividends (Tables)	3 Months Ended
	Nov. 30, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands): Three months ended November 30, 2023 November 30, 2022 Restricted stock units 654.4 365.9
Schedule of Cash Dividends Declared by the Company to Common Stockholders	The following table sets forth cash dividends declared by the Company to common stockholders during the three months ended November 30, 2023 and 2022 (in millions, except for per share data): Dividend Dividend Total of Cash Date of Record for Dividend Cash Fiscal Year 2024: October 19, 2023 $ 0.08 $ 11 November 15, 2023 December 4, 2023 Fiscal Year 2023: October 20, 2022 $ 0.08 $ 12 November 15, 2022 December 2, 2022

Business Acquisitions and Div_2

Business Acquisitions and Divestitures (Tables)	3 Months Ended
	Nov. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Assets and Liabilities Held For Sale	Following is a summary of the carrying amounts of the major classes of assets and liabilities that were classified as held for sale (in millions): November 30, 2023 August 31, 2023 Assets held for sale: Accounts receivable, net of allowance for credit losses $ 315 $ 96 Inventories, net of reserve for excess and obsolete inventory 354 559 Prepaid expenses and other current assets 153 220 Property, plant and equipment, net of accumulated depreciation 812 724 Operating lease right-of-use asset 119 112 Goodwill 117 117 Deferred income taxes 86 96 Liabilities held for sale: Accounts payable $ 992 $ 876 Accrued expenses 304 364 Non-current operating lease liabilities 86 83

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Nov. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Financial Assets and Liabilities	The following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated (in millions): Fair Value Hierarchy November 30, 2023 August 31, 2023 Assets: Prepaid expenses and other current assets: Short-term investments Level 1 $ 25 $ 25 Forward foreign exchange contracts: Derivatives designated as hedging instruments (Note 8) Level 2 (1) 10 4 Derivatives not designated as hedging instruments (Note 8) Level 2 (1) 18 20 Net investment hedges: Derivatives designated as hedging instruments (Note 8) Level 2 (1) 5 9 Liabilities: Accrued expenses: Forward foreign exchange contracts: Derivatives designated as hedging instruments (Note 8) Level 2 (1) $ 5 $ 17 Derivatives not designated as hedging instruments (Note 8) Level 2 (1) 17 64 Net investment hedges: Derivatives designated as hedging instruments (Note 8) Level 2 (1) 3 1 (1) The Company’s forward foreign exchange contracts, including cash flow hedges and net investment hedges are measured on a recurring basis at fair value, based on foreign currency spot rates and forward rates quoted by banks or foreign currency dealers.
Schedule of Carrying Amounts and Fair Values of Notes Payable and Long-term Debt	The following table presents the carrying amounts and fair values of the Company's notes payable and long-term debt, by hierarchy level as of the periods indicated (in millions): November 30, 2023 August 31, 2023 Fair Value Hierarchy Carrying Amount Fair Value Carrying Amount Fair Value Notes payable and long-term debt: (Note 4) 3.950% Senior Notes Level 2 (1) $ 497 $ 469 $ 497 $ 468 3.600% Senior Notes Level 2 (1) $ 497 $ 444 $ 496 $ 448 3.000% Senior Notes Level 2 (1) $ 593 $ 505 $ 593 $ 502 1.700% Senior Notes Level 2 (1) $ 498 $ 459 $ 498 $ 452 4.250% Senior Notes Level 2 (1) $ 495 $ 481 $ 495 $ 478 5.450% Senior Notes Level 2 (1) $ 296 $ 298 $ 296 $ 297 (1)

Trade Accounts Receivable Sal_3

Trade Accounts Receivable Sale Programs - Additional Information (Details) - 3 months ended Nov. 30, 2023	USD ($) program	CHF (SFr)	INR (₨)
USD
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount | $	$ 2,300,000,000
Number of programs	9
CHF
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount | SFr		SFr 100,000,000
Number of programs	1
INR
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount | ₨			₨ 8,100,000,000
Number of programs	1

Trade Accounts Receivable Sal_4

Trade Accounts Receivable Sale Programs - Trade Accounts Receivable Sale Programs Amounts Recognized (Details) - Trade Accounts Receivable Sale Programs - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Trade accounts receivable sold	$ 2,036	$ 3,528
Cash proceeds received	2,025	3,518
Pre-tax losses on sale of receivables	$ 11	$ 10

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Nov. 30, 2023	Aug. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 4,733	$ 4,804
Work in process	241	217
Finished goods	205	243
Reserve for excess and obsolete inventory	(55)	(58)
Inventories, net	5,124	5,206
Product Manufacturing Business | Held for sale
Inventory [Line Items]
Inventories, net classified as held for sale	$ 354	$ 559

Notes Payable and Long-Term D_3

Notes Payable and Long-Term Debt - Schedule of Notes Payable and Long-term Debt (Details) - USD ($)	Nov. 30, 2023	Aug. 31, 2023
Debt Instrument [Line Items]
Total notes payable and long-term debt	$ 2,876,000,000	$ 2,875,000,000
Less current installments of notes payable and long-term debt	0	0
Notes payable and long-term debt, less current installments	$ 2,876,000,000	2,875,000,000
Senior Notes | 3.950% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3.95%
Total notes payable and long-term debt	$ 497,000,000	497,000,000
Senior Notes | 3.600% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3.60%
Total notes payable and long-term debt	$ 497,000,000	496,000,000
Senior Notes | 3.000% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3%
Total notes payable and long-term debt	$ 593,000,000	593,000,000
Senior Notes | 1.700% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	1.70%
Total notes payable and long-term debt	$ 498,000,000	498,000,000
Senior Notes | 4.250% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.25%
Total notes payable and long-term debt	$ 495,000,000	495,000,000
Senior Notes | 5.450% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	5.45%
Total notes payable and long-term debt	$ 296,000,000	296,000,000
Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Total notes payable and long-term debt	0	0
Available unused borrowing capacity	3,800,000,000
Line of Credit | Term Loan Facility
Debt Instrument [Line Items]
Total notes payable and long-term debt	0	$ 0
Line of Credit | Commercial Paper
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 3,200,000,000

Notes Payable and Long-Term D_4

Notes Payable and Long-Term Debt - Additional Information (Details) - Senior Notes	Nov. 30, 2023
3.950% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3.95%
3.600% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3.60%
3.000% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3%
1.700% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	1.70%
4.250% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.25%
5.450% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	5.45%

Asset-Backed Securitization P_3

Asset-Backed Securitization Program - Additional Information (Details)	Nov. 30, 2023 USD ($)
Transfers and Servicing [Abstract]
Maximum amount of net cash proceeds	$ 600,000,000
Available liquidity under its asset-backed securitization programs (up to)	$ 0

Asset-Backed Securitization P_4

Asset-Backed Securitization Program - Securitization Activity (Details) - Asset-Backed Securitization Program - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Trade accounts receivable sold	$ 989	$ 1,066
Cash proceeds received	979	1,058
Pre-tax losses on sale of receivables	$ 10	$ 8

Accrued Expenses (Details)

Accrued Expenses (Details) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Aug. 31, 2023
Accrued Liabilities, Current [Abstract]
Inventory deposits	$ 1,656		$ 1,839
Contract liabilities	906		886
Accrued compensation and employee benefits	683		743
Other accrued expenses	2,595		2,047
Accrued expenses	5,840		5,515
Revenue recognized during period that was included in contract liability balance	161	$ 139
Held for sale | Product Manufacturing Business
Supplier Finance Program [Line Items]
Accrued expenses	$ 304		$ 364

Postretirement and Other Empl_3

Postretirement and Other Employee Benefits (Details) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Retirement Benefits [Abstract]
Service cost	$ 5	$ 4
Interest cost	3	3
Expected long-term return on plan assets	(4)	(5)
Recognized actuarial gain	(2)	(2)
Amortization of actuarial gains	(1)	(1)
Amortization of prior service cost	1	1
Net periodic benefit cost	$ 2	$ 0
Percentage of gain (loss) corridor	10%

Derivative Financial Instrume_3

Derivative Financial Instruments and Hedging Activities - Additional Information (Details) - Forward Contracts - Forward foreign exchange contracts - Cash flow hedging - USD ($) $ in Millions	Nov. 30, 2023	Aug. 31, 2023
Designated as hedging instruments
Derivative [Line Items]
Aggregate notional amount	$ 153	$ 491
Not designated as hedging instruments
Derivative [Line Items]
Aggregate notional amount	$ 4,300	$ 4,000

Derivative Financial Instrume_4

Derivative Financial Instruments and Hedging Activities - Schedule of Maturity Date and Aggregate Notional Amount Outstanding of Net Investment Hedges (Details) - Net investment hedges - Forward Contracts - Designated as hedging instruments - USD ($) $ in Millions	Nov. 30, 2023	Aug. 31, 2023
September 2023
Derivative [Line Items]
Aggregate notional amount	$ 0	$ 34
October 2023
Derivative [Line Items]
Aggregate notional amount	0	96
January 2024
Derivative [Line Items]
Aggregate notional amount	97	96
April 2024
Derivative [Line Items]
Aggregate notional amount	104	68
July 2024
Derivative [Line Items]
Aggregate notional amount	174	102
Foreign exchange contracts
Derivative [Line Items]
Aggregate notional amount	$ 375	$ 396

Derivative Financial Instrume_5

Derivative Financial Instruments and Hedging Activities - Fair Value of Derivative Instruments Recorded on Consolidated Statements of Operations (Details) - Forward foreign exchange contracts - Cost of revenue - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Net Income on Derivatives	$ 18	$ (46)
Foreign currency gains (losses)	$ (38)	$ 49

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income - Change in AOCI, Net of Tax (Details) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	$ 2,867	$ 2,452
Other comprehensive income (loss) before reclassifications	(3)
Amounts reclassified from AOCI	14
Total other comprehensive income	11	20
Ending Balance	2,536	2,530
AOCI Attributable to Parent
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(17)	(42)
Total other comprehensive income	11	20
Ending Balance	(6)	$ (22)
Foreign Currency Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(59)
Other comprehensive income (loss) before reclassifications	4
Amounts reclassified from AOCI	0
Total other comprehensive income	4
Ending Balance	(55)
Net Investment Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(4)
Other comprehensive income (loss) before reclassifications	(4)
Amounts reclassified from AOCI	0
Total other comprehensive income	(4)
Ending Balance	(8)
Derivative Instruments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	14
Other comprehensive income (loss) before reclassifications	(3)
Amounts reclassified from AOCI	16
Total other comprehensive income	13
Ending Balance	27
Actuarial Gain (Loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	46
Other comprehensive income (loss) before reclassifications	0
Amounts reclassified from AOCI	(3)
Total other comprehensive income	(3)
Ending Balance	43
Prior Service (Cost) Credit
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(14)
Other comprehensive income (loss) before reclassifications	0
Amounts reclassified from AOCI	1
Total other comprehensive income	1
Ending Balance	$ (13)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income - Reclassification from AOCI (Details) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of revenue	$ 7,612	$ 8,892
Other expense (income)	21	15
Total amounts reclassified from AOCI	(194)	(223)
Loss to be reclassified in next 12 months (less than)	5
Reclassification out of AOCI
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Total amounts reclassified from AOCI	14	41
Reclassification out of AOCI | Realized (gains) losses on derivative instruments | Foreign exchange contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of revenue	17	43
Reclassification out of AOCI | Realized (gains) losses on derivative instruments | Interest rate contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Interest expense	(1)	0
Reclassification out of AOCI | Actuarial gains
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Other expense (income)	(3)	(3)
Reclassification out of AOCI | Prior service costs
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Other expense (income)	$ 1	$ 1

Stockholders' Equity - Recogniz

Stockholders' Equity - Recognized Stock-Based Compensation (Details) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 46	$ 42
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	42	38
Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 4	$ 4

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) - shares	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Time-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Restricted stock units awarded (in shares)	400,000	900,000
Performance-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Restricted stock units awarded (in shares)	100,000	200,000
Performance-based restricted stock units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	150%
Market-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Restricted stock units awarded (in shares)	100,000	200,000
Market-based restricted stock units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	200%
2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available to be issued (in shares)	7,738,300

Stockholders' Equity - Stock-ba

Stockholders' Equity - Stock-based Compensation Information (Details) $ in Millions	3 Months Ended
	Nov. 30, 2023 USD ($)
Share-Based Payment Arrangement [Abstract]
Unrecognized stock-based compensation expense – restricted stock units	$ 82
Remaining weighted-average period for restricted stock units expense	1 year 6 months

Stockholders' Equity - Common S

Stockholders' Equity - Common Stock Outstanding (Details) - USD ($)	3 Months Ended		12 Months Ended	20 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Aug. 31, 2023	Feb. 28, 2023	Sep. 30, 2023	Sep. 30, 2022	Jul. 31, 2021
Common stock outstanding:
Common stock outstanding, beginning balances (in shares)	131,294,422
Common stock outstanding, ending balance (in shares)	128,647,431		131,294,422
2022 Share Repurchase Program
Common stock outstanding:
Share repurchase program, amount authorized							$ 1,000,000,000
Number of shares repurchased (in shares)				16,500,000
Value of shares repurchased				$ 1,000,000,000
Share repurchase program, remaining amount available				$ 0
2023 Share Repurchase Program
Common stock outstanding:
Share repurchase program, amount authorized					$ 2,500,000,000	$ 1,000,000,000
Number of shares repurchased (in shares)	3,900,000		2,700,000
Value of shares repurchased	$ 500,000,000		$ 224,000,000
Share repurchase program, remaining amount available	$ 2,000,000,000
Accelerated Share Repurchase Program
Common stock outstanding:
Share repurchase program, amount authorized					$ 500,000,000
Number of shares repurchased (in shares)	3,900,000
Average price (in usd per share)	$ 128.61
Common stock:
Common stock outstanding:
Common stock outstanding, beginning balances (in shares)	131,294,422	135,493,980	135,493,980
Vesting of restricted stock (in shares)	1,766,775	1,861,678
Purchases of treasury stock under employee stock plans (in shares)	(526,028)	(523,407)
Treasury shares purchased (in shares)	(3,887,738)	(2,600,951)
Common stock outstanding, ending balance (in shares)	128,647,431	134,231,300	131,294,422

Concentration of Risk and Seg_3

Concentration of Risk and Segment Data - Additional Information (Details)	3 Months Ended
	Nov. 30, 2023 country
Revenue, Major Customer [Line Items]
Number of operating countries (more than)	30
Five Largest Customers | Net revenue | Customer concentration
Revenue, Major Customer [Line Items]
Concentration risk	44%
76 customers | Net revenue | Customer concentration
Revenue, Major Customer [Line Items]
Concentration risk	90%

Concentration of Risk and Seg_4

Concentration of Risk and Segment Data - Segment Income (Details) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income	$ 235	$ 299
Reconciling items:
Amortization of intangibles	(6)	(8)
Stock-based compensation expense and related charges	(46)	(42)
Restructuring, severance and related charges	(127)	(45)
Costs from the divestiture of businesses	(15)	0
Interest expense, net	(47)	(48)
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income	499	461
Operating Segments | EMS
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income	165	198
Reconciling items:
Restructuring, severance and related charges	(29)	(4)
Operating Segments | DMS
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income	334	263
Reconciling items:
Restructuring, severance and related charges	(79)	(33)
Segment Reconciling Items
Reconciling items:
Amortization of intangibles	(6)	(8)
Stock-based compensation expense and related charges	(46)	(42)
Restructuring, severance and related charges	(127)	(45)
Costs from the divestiture of businesses	(15)	0
Other expense (net of periodic benefit cost)	(23)	(19)
Interest expense, net	$ (47)	$ (48)

Concentration of Risk and Seg_5

Concentration of Risk and Segment Data - Revenues Disaggregated by Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Disaggregation of Revenue [Line Items]
Net revenue	$ 8,387	$ 9,635
Point in time
Disaggregation of Revenue [Line Items]
Net revenue	3,109	3,818
Over time
Disaggregation of Revenue [Line Items]
Net revenue	5,278	5,817
EMS
Disaggregation of Revenue [Line Items]
Net revenue	3,592	4,546
EMS | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	1,095	1,538
EMS | Over time
Disaggregation of Revenue [Line Items]
Net revenue	2,497	3,008
DMS
Disaggregation of Revenue [Line Items]
Net revenue	4,795	5,089
DMS | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	2,014	2,280
DMS | Over time
Disaggregation of Revenue [Line Items]
Net revenue	$ 2,781	$ 2,809

Concentration of Risk and Seg_6

Concentration of Risk and Segment Data - Foreign Source Revenue (Details)	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Foreign source revenue | Net revenue | Foreign source revenue
Concentration Risk [Line Items]
Concentration risk	86.40%	85.70%

Restructuring, Severance and _3

Restructuring, Severance and Related Charges (Details) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	$ 127	$ 45
Operating Segments | EMS
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	29	4
Operating Segments | DMS
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	79	33
Non-allocated charges
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	19	8
Employee severance and benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	95	40
Asset write-off costs
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	22	1
Other costs
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	$ 10	$ 4

Restructuring, Severance and _4

Restructuring, Severance and Related Charges - Additional Information (Details) $ in Millions	Nov. 30, 2023 USD ($)
2024 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Total pre-tax restructuring and other related costs expected to be recognized	$ 300

Restructuring, Severance and _5

Restructuring, Severance and Related Charges - Liability Activity (Details) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Restructuring Reserve [Roll Forward]
Restructuring related charges	$ 127	$ 45
Employee  Severance and Benefit Costs
Restructuring Reserve [Roll Forward]
Restructuring related charges	95	40
Asset Write-off Costs
Restructuring Reserve [Roll Forward]
Restructuring related charges	22	1
Other Related Costs
Restructuring Reserve [Roll Forward]
Restructuring related charges	10	$ 4
2024 Restructuring Plan
Restructuring Reserve [Roll Forward]
Beginning balance	0
Restructuring related charges	127
Asset write-off charge and other non-cash activity	(27)
Cash payments	(14)
Ending balance	86
2024 Restructuring Plan | Employee  Severance and Benefit Costs
Restructuring Reserve [Roll Forward]
Beginning balance	0
Restructuring related charges	95
Asset write-off charge and other non-cash activity	0
Cash payments	(14)
Ending balance	81
2024 Restructuring Plan | Lease Costs
Restructuring Reserve [Roll Forward]
Beginning balance	0
Restructuring related charges	0
Asset write-off charge and other non-cash activity	0
Cash payments	0
Ending balance	0
2024 Restructuring Plan | Asset Write-off Costs
Restructuring Reserve [Roll Forward]
Beginning balance	0
Restructuring related charges	22
Asset write-off charge and other non-cash activity	(22)
Cash payments	0
Ending balance	0
2024 Restructuring Plan | Other Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance	0
Restructuring related charges	10
Asset write-off charge and other non-cash activity	(5)
Cash payments	0
Ending balance	$ 5

Income Taxes - Schedule of U.S.

Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate Compared to Actual Income Tax Expense (Details)	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Income Tax Disclosure [Abstract]
U.S. federal statutory income tax rate	21%	21%
Effective income tax rate	17.60%	25.60%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) $ in Millions	3 Months Ended
	Nov. 30, 2023 USD ($)
Income Tax Disclosure [Abstract]
Income tax benefit for audit closure	$ 19
Reversal of valuation allowance	$ 11

Earnings Per Share and Divide_3

Earnings Per Share and Dividends - Earnings Per Share (Details) - shares	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common shares excluded from computation of diluted earnings per share (in shares)	654,400	365,900

Earnings Per Share and Divide_4

Earnings Per Share and Dividends - Cash Dividends Declared by the Company to Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Millions	Oct. 19, 2023	Oct. 20, 2022
Earnings Per Share [Abstract]
Dividends per Share (in usd per share)	$ 0.08	$ 0.08
Total of Cash Dividends Declared	$ 11	$ 12

Business Acquisitions and Div_3

Business Acquisitions and Divestitures - Additional Information (Details) - USD ($) $ in Millions	Nov. 01, 2023	Nov. 30, 2023	Sep. 26, 2023	Aug. 31, 2023
Business Acquisition [Line Items]
Goodwill		$ 661		$ 621
Held for sale | Product Manufacturing Business
Business Acquisition [Line Items]
Consideration for the sale of a business			$ 2,200
ProcureAbility Inc.
Business Acquisition [Line Items]
Amount of cash paid for business acquisitions	$ 60
Assets acquired	86
Intangible assets	40
Goodwill	38
Liabilities assumed	$ 25

Business Acquisitions and Div_4

Business Acquisitions and Divestitures - Schedule of Assets and Liabilities Held For Sale (Details) - Held for sale - Product Manufacturing Business - USD ($) $ in Millions	Nov. 30, 2023	Aug. 31, 2023
Assets held for sale:
Accounts receivable, net of allowance for credit losses	$ 315	$ 96
Prepaid expenses and other current assets	153	220
Property, plant and equipment, net of accumulated depreciation	812	724
Operating lease right-of-use asset	119	112
Goodwill	117	117
Deferred income taxes	86	96
Liabilities held for sale:
Accounts payable	992	876
Accrued expenses	304	364
Non-current operating lease liabilities	$ 86	$ 83

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Measurements on a Recurring Basis (Details) - Recurring - USD ($) $ in Millions	Nov. 30, 2023	Aug. 31, 2023
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments	$ 25	$ 25
Level 2 | Designated as hedging instruments | Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	10	4
Derivative liability	5	17
Level 2 | Designated as hedging instruments | Net investment hedges
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	5	9
Derivative liability	3	1
Level 2 | Not designated as hedging instruments | Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	18	20
Derivative liability	$ 17	$ 64

Fair Value Measurements - Fai_2

Fair Value Measurements - Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Nov. 30, 2023	Aug. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	$ 2,876	$ 2,875
Senior Notes | 3.950% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	3.95%
Carrying Amount	$ 497	497
Senior Notes | 3.600% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	3.60%
Carrying Amount	$ 497	496
Senior Notes | 3.000% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	3%
Carrying Amount	$ 593	593
Senior Notes | 1.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	1.70%
Carrying Amount	$ 498	498
Senior Notes | 4.250% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	4.25%
Carrying Amount	$ 495	495
Senior Notes | 5.450% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	5.45%
Carrying Amount	$ 296	296
Senior Notes | Carrying Amount | Level 2 | 3.950% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	497	497
Senior Notes | Carrying Amount | Level 2 | 3.600% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	497	496
Senior Notes | Carrying Amount | Level 2 | 3.000% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	593	593
Senior Notes | Carrying Amount | Level 2 | 1.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	498	498
Senior Notes | Carrying Amount | Level 2 | 4.250% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	495	495
Senior Notes | Carrying Amount | Level 2 | 5.450% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	296	296
Senior Notes | Fair Value | Level 2 | 3.950% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	469	468
Senior Notes | Fair Value | Level 2 | 3.600% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	444	448
Senior Notes | Fair Value | Level 2 | 3.000% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	505	502
Senior Notes | Fair Value | Level 2 | 1.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	459	452
Senior Notes | Fair Value | Level 2 | 4.250% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	481	478
Senior Notes | Fair Value | Level 2 | 5.450% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 298	$ 297